Mindray Medical International (MR) Tops Q2 EPS by 4c; Maintains Outlook
Tweet
Share
E-mailGet Alerts MR Hot Sheet
Join SI Premium – FREE
Mindray Medical International (NYSE: MR) reported Q2 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $217.3 million versus the consensus estimate of $212.19 million.
Maintains outlook.
Maintains outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
